67.00
2.98%
-2.06
Handel nachbörslich:
67.10
0.10
+0.15%
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
7.41%
29.29
|
27.27 | 23.74 | 20.54 | 20.28 |
Operating Income/Loss |
7.41%
-29.29
|
-27.27 | -23.74 | -20.54 | -20.28 |
Income/Loss From Continuing Operations Before Tax |
9.19%
-24.60
|
-22.53 | -19.23 | -19.53 | -19.56 |
Income/Loss From Continuing Operations After Tax |
9.19%
-24.61
|
-22.53 | -19.23 | -19.53 | -19.56 |
Net Income/Loss
|
9.19%
-24.61
|
-22.53 | -19.23 | -19.53 | -19.56 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.13%
1.866
|
99.85 | 99.01 | 78.35 | -0.083 |
Diluted Average Shares |
98.13%
1.866
|
99.85 | 99.01 | 78.35 | -0.083 |
Basic Earnings Per Share |
8.70%
-0.25
|
-0.23 | -0.19 | -0.25 | -0.26 |
Diluted Earnings Per Share |
8.70%
-0.25
|
-0.23 | -0.19 | -0.25 | -0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):